All data are based on the daily closing price as of September 9, 2025
l
Lotus Pharmaceutical
1795.TW
6.36 USD
0.01
+0.16%
Overview
Last close
6.36 usd
Market cap
1.66B usd
52 week high
10.59 usd
52 week low
5.34 usd
Target price
10.65 usd
Valuation
P/E
10.4167
Forward P/E
N/A
Price/Sales
2.6353
Price/Book Value
2.4871
Enterprise Value
1.92B usd
EV/Revenue
3.0415
EV/EBITDA
7.3694
Key financials
Revenue TTM
631.65M usd
Gross Profit TTM
378.26M usd
EBITDA TTM
256.17M usd
Earnings per Share
0.61 usd
Dividend
0.19 usd
Total assets
1.31B usd
Net debt
248.90M usd
About
Lotus Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally. Its product portfolio focuses on generics in the fields of oncology, central nervous system, cardiovascular diseases, woman health, and anti-obesity. The company also engages in retail of clinical machines; biotech technological consulting services; sale of pharmaceuticals and medicinal chemical products; marketing activities; market planning and business information services; and consultancy services on health management, health technology, and trading information services. In addition, it offers management consultancy services; pharmaceutical regulatory affairs project management, and data collection and agency services; healthcare consultancy services and operates as a contract research organization. Lotus Pharmaceutical Co., Ltd. was incorporated in 1966 and is headquartered in Taipei City, Taiwan.